Loading Profile


Loading

Kenward Johnson

Current Research

Pharmacogenomics with an emphasis on development of biomarker signatures of chemotherapy induced neuropathic pain from gene variants, epigenetic mechanisms to include DNA methylation & microRNAs, and mRNA expression of genes associated with pain and neuroinflammation. Clinical pharmacology of sedative-opioid interactions, hemorrhagic shock & intravenous anesthetics, new clinical applications of remimazolam, and of approaches to total intravenous anesthesia.